| Dr Kamran Shayesteh, DO | |
|
1 Tech Park Dr Ste 1200, Johnstown, PA 15901-2515 | |
| (814) 534-6750 | |
| (814) 535-6760 |
| Full Name | Dr Kamran Shayesteh |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 25 Years |
| Location | 1 Tech Park Dr Ste 1200, Johnstown, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336150564 | NPI | - | NPPES |
| 1025321390001 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0122X | Surgery - Plastic And Reconstructive Surgery | OS012172 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Conemaugh Memorial Medical Center | Johnstown, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dlp Conemaugh Physician Practices Llc | 7315166949 | 253 |
News Archive
Delirium accompanied by fever could bean early symptom of COVID-19. This is the main conclusion drawn by a scientific research review carried out by researchers from the Universitat Oberta de Catalunya.
One year post-surgery, patients who underwent Descemet's stripping automated endothelial keratoplasty (DSAEK) experienced greater cell loss overall compared to those who underwent penetrating keratoplasty (PKP), according to a new analysis of data collected from the Cornea Donor Study (CDS) Investigator Group's 2008 Specular Microscopy Ancillary Study (SMAS). However, the study, published in the March issue of Ophthalmology, showed that cell loss in DSAEK patients plateaued more quickly than in those who underwent PKP.
What if there was a drug that could simultaneously curb a person's craving for alcohol while also protecting their heart and liver from alcohol's damaging effects?
H1N1 has led to increased focus on how everyday hygiene affects our health. Not only is more attention given to managing personal hygiene, but a new cleaning logic is emerging, where wiping the door knob an extra time1 each day is considered more important than picking up the dust in the corner.
Sucampo Pharmaceuticals, Inc., a global biopharmaceutical company, today announced that it has received orphan drug designation in the European Union for unoprostone isopropyl for the treatment of retinitis pigmentosa (RP). RP is a genetic disease characterized by progressive, irreversible vision loss and decreasing visual acuity, and there are no drugs or therapeutic procedures currently approved for the treatment of RP today.
› Verified 1 days ago
| Entity Name | Dlp Conemaugh Physician Practices Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932515905 PECOS PAC ID: 7315166949 Enrollment ID: O20140915002522 |
News Archive
Delirium accompanied by fever could bean early symptom of COVID-19. This is the main conclusion drawn by a scientific research review carried out by researchers from the Universitat Oberta de Catalunya.
One year post-surgery, patients who underwent Descemet's stripping automated endothelial keratoplasty (DSAEK) experienced greater cell loss overall compared to those who underwent penetrating keratoplasty (PKP), according to a new analysis of data collected from the Cornea Donor Study (CDS) Investigator Group's 2008 Specular Microscopy Ancillary Study (SMAS). However, the study, published in the March issue of Ophthalmology, showed that cell loss in DSAEK patients plateaued more quickly than in those who underwent PKP.
What if there was a drug that could simultaneously curb a person's craving for alcohol while also protecting their heart and liver from alcohol's damaging effects?
H1N1 has led to increased focus on how everyday hygiene affects our health. Not only is more attention given to managing personal hygiene, but a new cleaning logic is emerging, where wiping the door knob an extra time1 each day is considered more important than picking up the dust in the corner.
Sucampo Pharmaceuticals, Inc., a global biopharmaceutical company, today announced that it has received orphan drug designation in the European Union for unoprostone isopropyl for the treatment of retinitis pigmentosa (RP). RP is a genetic disease characterized by progressive, irreversible vision loss and decreasing visual acuity, and there are no drugs or therapeutic procedures currently approved for the treatment of RP today.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kamran Shayesteh, DO 1086 Franklin St, Johnstown, PA 15905-4305 Ph: (814) 410-8300 | Dr Kamran Shayesteh, DO 1 Tech Park Dr Ste 1200, Johnstown, PA 15901-2515 Ph: (814) 534-6750 |
News Archive
Delirium accompanied by fever could bean early symptom of COVID-19. This is the main conclusion drawn by a scientific research review carried out by researchers from the Universitat Oberta de Catalunya.
One year post-surgery, patients who underwent Descemet's stripping automated endothelial keratoplasty (DSAEK) experienced greater cell loss overall compared to those who underwent penetrating keratoplasty (PKP), according to a new analysis of data collected from the Cornea Donor Study (CDS) Investigator Group's 2008 Specular Microscopy Ancillary Study (SMAS). However, the study, published in the March issue of Ophthalmology, showed that cell loss in DSAEK patients plateaued more quickly than in those who underwent PKP.
What if there was a drug that could simultaneously curb a person's craving for alcohol while also protecting their heart and liver from alcohol's damaging effects?
H1N1 has led to increased focus on how everyday hygiene affects our health. Not only is more attention given to managing personal hygiene, but a new cleaning logic is emerging, where wiping the door knob an extra time1 each day is considered more important than picking up the dust in the corner.
Sucampo Pharmaceuticals, Inc., a global biopharmaceutical company, today announced that it has received orphan drug designation in the European Union for unoprostone isopropyl for the treatment of retinitis pigmentosa (RP). RP is a genetic disease characterized by progressive, irreversible vision loss and decreasing visual acuity, and there are no drugs or therapeutic procedures currently approved for the treatment of RP today.
› Verified 1 days ago
Bradley Stephen Winegardner, Surgery Medicare: Medicare Enrolled Practice Location: 1086 Franklin St, Johnstown, PA 15905 Phone: 814-534-1660 | |
Gerard A Garguilo, MD Surgery Medicare: Medicare Enrolled Practice Location: 1111 Franklin St, Ste 030, Johnstown, PA 15905 Phone: 814-539-6797 Fax: 814-535-8400 | |
Ruth N Cho, D.O. Surgery Medicare: Medicare Enrolled Practice Location: 1086 Franklin St, Johnstown, PA 15905 Phone: 814-534-1660 Fax: 814-534-1680 | |
Flavia Davit, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1086 Franklin St, Johnstown, PA 15905 Phone: 814-534-9756 Fax: 814-534-3279 | |
Magdi Azer, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 320 Main St, 1st Floor, Johnstown, PA 15901 Phone: 814-534-1770 Fax: 814-534-1942 | |
Dr. Daniel R Nevarre, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 415 Napoleon Pl, Johnstown, PA 15901 Phone: 814-536-9000 | |
Jennifer Silvis, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 1086 Franklin St, Johnstown, PA 15905 Phone: 814-534-1660 Fax: 814-534-1680 |